Uncovering the genetic landscape of cholangiocarcinoma and its subtypes via GWAS and integrative analyses
Younghun Han(University of New Mexico), Rory L. Smoot(Mayo Clinic), Shahid Ali Khan(City University of Hong Kong), Jeanine M. Genkinger(Columbia University Irving Medical Center), Robin Kate Kelley(UCSF Helen Diller Family Comprehensive Cancer Center), Niklas K. Björkström(Karolinska University Hospital), Rikita Hatia(The University of Texas MD Anderson Cancer Center), Sandi A. Kwee(University of Hawaiʻi at Mānoa), Fowsiyo Ahmed(Mayo Clinic), Martin Cornillet(Karolinska University Hospital), S. Cleary(University of Toronto), L. Bujanda(University of the Basque Country), Sumera Ilyas(Mayo Clinic), Richard D. Kim(Moffitt Cancer Center), Trine Folseraas(Oslo University Hospital), Troels Dreier Christensen(University of Copenhagen), Carlos H.F. Chan(University of Iowa Hospitals and Clinics), F Lammert(Medizinische Hochschule Hannover), Lipika Goyal(Stanford Medicine), Oliver F. Bathe(University of Calgary), Hawa M. Ali(Mayo Clinic in Arizona), Matthew A. Cooley(Mayo Clinic), Stacie Lindsey(Cholangiocarcinoma Foundation), Helen L. Reeves(Newcastle upon Tyne Hospital), Caitlin J. VanLith(Mayo Clinic in Florida), Jesús M. Bañales(University of the Basque Country), Nellie A. Campbell(Mayo Clinic), Tushar Patel(WinnMed), Ashwin S. Kamath(Allina Health), Nasra H. Giama(Mayo Clinic), Victor Ankoma-Sey, Mitesh J. Borad(Mayo Clinic Hospital), Jinyoung Byun(University of New Mexico), P R Galle(Johannes Gutenberg University Mainz), Stephen Rossi(PSC Partners Seeking a Cure), Tanios S. Bekaii-Saab(Mayo Clinic Hospital), Richard S. Houlston(Institute of Cancer Research), Gregory J. Gores(Mayo Clinic), Mohamed Hassan(Mayo Clinic), Rocio I. R. Macias(Universidad de Salamanca), Vikram R. Shaw(Baylor College of Medicine), Jennifer B. Permuth(Moffitt Cancer Center), Julia S. Johansen(Gentofte Hospital), Angela Lamarca(University of Manchester), William Sanchez(Mayo Clinic), Milind Javle(The University of Texas MD Anderson Cancer Center), Jesper B. Andersen(University of Copenhagen), Harmeet Malhi(Mayo Clinic), Robert J. MacInnis(The University of Melbourne), Nicholas F. LaRusso(Mayo Clinic)
Cited by 1
Related Papers
Hepatocellular carcinoma
|Nature Reviews Disease Primers|2021|6.6k
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
|Journal of Clinical Oncology|2014|2.8k
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k